Asset Details
Do you wish to reserve the book?
Eliciting B cell immunity against infectious diseases using nanovaccines
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Eliciting B cell immunity against infectious diseases using nanovaccines
Do you wish to request the book?
Eliciting B cell immunity against infectious diseases using nanovaccines
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Eliciting B cell immunity against infectious diseases using nanovaccines
2021
Overview
Infectious diseases, including the coronavirus disease 2019 (COVID-19) pandemic that has brought the world to a standstill, are emerging at an unprecedented rate with a substantial impact on public health and global economies. For many life-threatening global infectious diseases, such as human immunodeficiency virus (HIV) infection, malaria and influenza, effective vaccinations are still lacking. There are numerous roadblocks to developing new vaccines, including a limited understanding of immune correlates of protection to these global infections. To induce a reproducible, strong immune response against difficult pathogens, sophisticated nanovaccine technologies are under investigation. In contrast to conventional vaccines, nanovaccines provide improved access to lymph nodes, optimal packing and presentation of antigens, and induction of a persistent immune response. This Review provides a perspective on the global trends in emerging nanoscale vaccines for infectious diseases and describes the biological, experimental and logistical problems associated with their development, and how immunoengineering can be leveraged to overcome these challenges.
This Review provides an overview of the advantages and disadvantages of nanoscale vaccines against infectious diseases, focusing in particular on the immunological responses they can elicit, depending on their physicochemical properties and functionalization, and on the challenges their production face.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
/ Animals
/ Antibody-Dependent Enhancement
/ Antigens
/ Chemistry and Materials Science
/ Communicable Diseases - immunology
/ Communicable Diseases - pathology
/ COVID-19
/ HIV
/ Human immunodeficiency virus
/ Humans
/ Immunity
/ Malaria
/ Mutation
/ Nanoparticles - administration & dosage
/ Nanotechnology and Microengineering
/ Vaccines
